Skip to content

Case Control Study to Identify Modifiable Risk Factors for Colorectal and Breast Cancer in Nigeria

Case Control Study to Identify Modifiable Risk Factors for Colorectal and Breast Cancer in Nigeria

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05044689
Enrollment
800
Registered
2021-09-16
Start date
2021-04-12
Completion date
2026-12-31
Last updated
2025-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Colorectal Cancer

Brief summary

This project is a case-control study which seeks to identify modifiable risk factors for breast and colorectal cancer in Nigeria. Both cases and controls will be required to complete a risk factor questionnaire which contains information about their diet, physical activity, past medical history and life style factors. They will also be required to provide information on their body composition through the use of a bioimpedance machine which measures the body mass index, fat and total body water percentage. Based on the existing ARGO platform where a current colorectal cancer study is going on, approximately 400 patients with a prior diagnosis or a new diagnosis will be recruited into this study. Comparatively, we will select our 400 controls from two groups of participants who are free of cancer and gastrointestinal diseases.

Interventions

BEHAVIORALQuestionnaire

Questionnaire containing questions regarding diet, physical activity, past medical history and life style practices.

DEVICEBioimpedance/Body Composition Unit

Patients will provide information on body composition through the use of a bioimpedance machine which measures the body mass index, fat and total body water.

Sponsors

Memorial Sloan Kettering Cancer Center
CollaboratorOTHER
Lagos State University
CollaboratorOTHER
University of Ilorin Teaching Hospital
CollaboratorOTHER
Federal Medical Centre, Owo
CollaboratorINDUSTRY
University of Maiduguri Teaching Hospital
CollaboratorUNKNOWN
National Hospital, Abuja
CollaboratorOTHER_GOV
Obafemi Awolowo University Teaching Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

Case Group - Patients must have histologically confirmed diagnosis of colorectal or breast cancer. Control Group - Patients must not have a diagnosis of cancer.

Design outcomes

Primary

MeasureTime frameDescription
Development and Validation of Questionnaire For Assessing Modifiable Risk Factors for Cancer in Sub-Saharan Africa2 years
Determination of Novel Modifiable Cancer Risk Factors in a Nigerian Population2 yearsWe will determine the presence of established, plausible, and novel cancer risk factors in cases (n=400) and controls (n=400) in Nigeria

Countries

Nigeria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026